Phage therapy program
University of Maryland School of Medicine — James Doub clinical research
| Status | Intake unconfirmed |
|---|---|
| Type | Center |
| Location | Baltimore, Maryland; United States |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Current faculty profile lists jdoub@ihv.umaryland.edu and clinical research in recalcitrant prosthetic joint infection. No current dedicated new-patient phage intake form verified. |
|---|---|
| Areas of work | Clinical/translational musculoskeletal infection program and phage research; profile reports treatment protocols and research funding. |
| International access | No public international-patient eligibility or acceptance policy verified. |
What to confirm
- Profile retains a trial-start-in-2022 statement; that text is stale. Published clinical expertise is not evidence of current general intake.
Related studies(1)
ACTIVE2
Withdrawn
Recorded program–study link. Website
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | maryland-doub |
|---|